CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 23 No. 13
INTEGRATIVE ONCOLOGY 

Oxygen Therapies

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | December 1, 2009
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Oxygen therapies are expensive, unproven, and harmful alternatives promoted in appealing and convincing ways for the treatment of cancer and other major diseases. Supporters claim that low levels of oxygen enable cancer cells to thrive and that an oxygen-rich environment destroys them. However, these claims are unsubstantiated. Further, numerous reports of serious complications and fatalities have been reported from the use of oxygen therapies.

The American Cancer Society strongly urges cancer patients not to seek oxygen treatments. Patients should be advised to avoid questionable, alternative treatments and informed of the dangers associated with these therapies.

—Barrie Cassileth, PhD

ALSO KNOWN AS: Oxymedicine, bio-oxidative therapy, oxidative therapy, oxidology, hydrogen peroxide(Drug information on hydrogen peroxide) therapy, ozone therapy, ozonolysis, hyperoxygenation therapies, hyperoxygenated water.

SUMMARY: Oxygen therapies are unproven alternatives promoted as a cure for cancer, acquired immune deficiency syndrome (AIDS), and other degenerative diseases. These “therapies” are offered at clinics in Mexico, the United States, and Europe. Proponents claim that many diseases, including cancer, are caused by oxygen deficiency and that oxygenation can restore health by destroying cancer cells, eliminating pathogens, stimulating metabolism, and by producing “oxidative detoxification.” There is no scientific evidence to support any of these claims.

Oxygen therapies include: (1) hydrogen peroxide therapy involving intravenous infusion, ingestion, colonic administration, or soaking in hydrogen peroxide solution; (2) ozone colonics and ozone autohemotherapy, in which blood is withdrawn and treated with ozone before reinfusion, and (3) “oxygenated” water, pills, and solutions.

The use of oxygen therapies has resulted in serious adverse events and several deaths.

Oxygen therapies should not be confused with those commonly used in respiratory care.

ADVERSE EFFECTS: Common (intrarectal hydrogen peroxide): Numerous cases of hydrogen peroxide-induced ulcerative colitis and sepsis have been reported.[1]

Case Report (intravenous hydrogen peroxide): In a 51-year-old AIDS patient, injection of 35% hydrogen peroxide into the subclavian vein catheter caused Heinz body hemolytic anemia, subsequent hemoglobinuria, and death from progressive renal insufficiency with multiple electrolyte abnormalities.[2] Case Report (oral hydrogen peroxide): Ingestion of 30% to 40% hydrogen peroxide solution resulted in three deaths from gas embolism and circulatory collapse.[3]

In addition, two cases of cerebral embolism were reported after ingestion of 30% to 40% hydrogen peroxide solution.[4,5] Common (subcutaneous ozone): Local pain, burning, erythema, edema, and hematoma.[6]

Transmission of blood-borne viruses such as hepatitis C and HIV was reported after treatment with contaminated autohemotherapy devices.[7]

DRUG INTERACTIONS: Oxygen may potentiate the pulmonary toxicity of bleomycin(Drug information on bleomycin).[8]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Andrew Nash | March 30, 2010 9:01 AM EDT

Binh: The complete item has been posted. This is just a one-page overview. For more information, we encourage you to visit Memorial Sloan-Kettering's Integrative Medicine site here: http://www.mskcc.org/mskcc/html/69317.cfm





REFERENCES: 1. Shaw A, Cooperman A, Fusco J: Gas embolism produced by hydrogen peroxide. N Engl J Med 277:238-241, 1967.
2. Hirschtick RE, Dyrda SE, Peterson LC: Death from an unconventional therapy for AIDS. Ann Intern Med 120:694, 1994.
3. Meyer CT, Brand M, DeLuca VA, et al: Hydrogen peroxide colitis: A report of three patients. J Clin Gastroenterol 3:31-35, 1981.
4. Giberson TP, Kern JD, Pettigrew DW 3rd, et al: Near-fatal hydrogen peroxide ingestion. Ann Emerg Med 18:778-779, 1989.
5. Sherman SJ, Boyer LV, Sibley WA: Cerebral infarction immediately after ingestion of hydrogen peroxide solution. Stroke 25:1065-1067, 1994.
6. Franzini M, et al: Subcutaneous oxygen-ozone therapy in indurative hypodermatitis and in localized lipodystrophies: A clinical study of efficacy and tolerability. Acta Toxicol Ther 14:273-288, 1993.
7. Daschner FD: Hepatitis C and human immunodeficiency virus infection following ozone autohemotherapy. Eur J Clin Microbiol Infect Dis 16:620, 1997.
8. Ingrassia TS 3rd, Ryu JH, Trastek VF, et al: Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 66:173-178, 1991.


 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY:
Perspectives on Best Practices

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
IMAGE IQ

This patient is at increased risk for which type of neoplasia?

A 28-year-old, slightly obese Caucasian woman presented with a long-standing history of intermittently painful “bumps” on both shoulders and her upper back.

 

More Image IQs:

 

 
FROM PHYSICIANS PRACTICE
Tax Schemes Every Physician Should Avoid
Ike Devji, JD, January 31, 2012
The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Boosting Collections at Your Medical Practice: Whose Job Is It?
P.J. Cloud-Moulds, January 28, 2012
Embrace the relationship between your billing company and your medical practice staff.
Managing Difficult Medical Practice Employees
Shelly K. Schwartz, January 27, 2012
Tips for transforming immature staff members into great employees.
Prevent Physician Distraction When Using mHealth Technology
Aubrey Westgate, January 25, 2012
As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice?
Karen Zupko, January 25, 2012
If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Head and Neck Tumors
  • 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Evolution of Treatment Options for Patients With CRPC and Bone Metastases: Bone-Targeted Agents That Go Beyond Palliation of Symptoms to Improve Overall Survival
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • New Mutation May Act as Driver in Subset of Lung Cancer Patients
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • Advances and New Research in the Treatment of Kidney Cancer
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • Vismodegib Granted FDA Approval for Treatment of Basal Cell Carcinoma
  • FDA Grants Approval to Axitinib for the Treatment of Advanced Renal Cell Carcinoma
  • Why BRAF-Mutated Colorectal Cancers Don't Respond to BRAF Inhibitors
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy